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EFFECTS OF ALENDRONATE ON ARTICULAR CARTILAGE
AND SUBCHONDRAL BONE CHANGES IN A RABBIT
MODEL OF OSTEOARTHRITIS
T. Shirai1, M. Kobayashi1, K. Nishitani1, T. Satake1, H. Kuroki1,
Y. Nakagawa2, T. Nakamura1
1Kyoto Univ., Kyoto, Japan; 2Kyoto Med. Ctr., Kyoto, Japan
Purpose: It is generally recognized that osteoarthritis (OA) is a
complex multifactorial disease process involving articular carti-
lage, subchondral bone, tendons, and synovium. The aim of this
study was to examine whether alendronate (ALN) altered cartilage
degeneration and periarticular bone quality in the rabbit anterior
cruciate ligament transection (ACLT) model of osteoarthritis (OA).
Methods: Skeletally matured, thirty Japanese white rabbits under-
went ACLT on the left knee (ACLT knee) and sham operation on
the right knee (sham knee). Fifteen rabbits then received weekly
subcutaneous injection of ALN (0.14mg/kg) beginning on the day
after the surgery and the other 15 rabbits received subcutaneous
injections of saline as control on the same schedule. Each 5 ani-
mals were sacriﬁced at 2, 4 or 12 weeks post-surgery, respectively.
Assays for serum N-telopeptide of type I collagen (NTX) level were
performed before treatment of ALN and after sacriﬁced. The ar-
ticular cartilage was evaluated macroscopically. Signal intensity
(index of stiffness), signal duration (index of surface irregularity)
and interval between signals (index of thickness) of the ultrasound
reﬂection from the articular cartilage on the femoral condyle were
also evaluated using high-frequency pulse-echo ultrasound sys-
tem. The distal femur and the proximal tibia were scanned by
micro-computed tomography to quantify the thickness of subchon-
dral plate and the bone volume ratio (BV/TV).
Results: Twelve weeks after the surgery, macroscopic view
showed that the ACLT knee had signiﬁcantly worse cartilage
damage and ﬁbrillation than the sham knee in the control group.
However, in the ALN group, the ACLT knee had mild cartilage
degeneration, and the difference of cartilage damage between
the ACLT knee and the sham knee was not signiﬁcant when the
macroscopic view was scored. Serum NTX level was suppressed
by ALN at 4 weeks post-surgery. In the control group, the signal
intensity of articular cartilage on the femoral condyle of the ACLT
knee was signiﬁcantly less than that of the sham knee at 4 and
12 weeks post-operatively. But in the ALN group, the intensity of
cartilage of the ACLT knee was not signiﬁcantly different from that
of the sham knee at all time periods. There was no difference
between ALN and control groups in the signal duration and the
interval between signals of cartilage on the femoral condyle. The
BV/TV of the proximal tibia of the bilateral knee was higher in
the ALN group than in the control group at 12 weeks after the
surgery. Although the BV/TV of the distal femur in the ALN group
tended to be higher than the one in the control group at 12 weeks
post-surgery, there was no signiﬁcant difference. The thickness
of subchondral plate of the femur and the tibia was not different
between two groups.
Conclusions: Macroscopic ﬁndings and the ultrasound signal in-
tensity demonstrated that ALN was chondroprotective. Although
the difference of cartilage damage between the ALN group and
the control group was detected at 12 weeks after surgery macro-
scopically, the index of stiffness of cartilage in the ALN group was
already clearly high compared to that of cartilage in the control
group 4 weeks after surgery. The cartilage degradative changes
are attenuated by ALN in the experimental rabbit OA models.
In addition, ALN treatment inhibited subchondral bone resorption
of the proximal tibia in the OA joint 12 weeks post-surgery. Our
results may suggest a therapeutic role for ALN to inhibit subchon-
dral bone loss in the early OA stage, protect against cartilage
degeneration, and potentially conserve long-term joint function.
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ACTIVE INVOLVEMENT OF “ALARMINS” S100A8 AND A9 IN
REGULATION OF SYNOVIAL ACTIVATION AND JOINT
DESTRUCTION DURING OSTEOARTHRITIS
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Purpose: Prominent proteins released by activated macrophages
are the “alarmins” S100 A8 and A9. Both proteins accumulate in in-
ﬂammatory synovial ﬂuids and have been postulated to be involved
in the pathogenesis of rheumatic diseases like RA. S100A8 is as-
sumed to be the active component whereas S100A9 functions as
the regulatory subunit preventing S100A8 from degradation. The
aim is to study the active involvement of S100A8/A9 in synovial
activation and cartilage destruction in two models of osteoarthritis.
Methods: Experimental OA was either induced by injection of
collagenase into murine knee joints, which causes local instability
or by transsection of the medial anterior meniscotibial ligament
which leads to destabilisation of the medial meniscus (DMM).
OA phenotypes were studied within 8 weeks after induction.
Collagenase-induced-osteoarthritis involves chronic synovial ac-
tivation in contrast to DMM. Synovial expression of S100A8 and
S100A9 during the course of osteoarthritis was performed using
immunolocalisation. Both models were induced in S100A9-/- deﬁ-
cient mice (myeloid cells also lack S100A8 at the protein level).
Synovial activation and cartilage destruction was measured by
histology. Cartilage pathology was scored in a blinded way using
an arbitrary score that considered both grade (0-6) and stage (0-5)
of pathology. MMP-mediated cartilage destruction was measured
with immunolocalisation using anti-VDIPEN antibodies.
Results: Kinetic studies show that S100A8 and S100A9 expres-
sion were clearly detected in synovial macrophages during the
course of collagenase-induced osteoarthritis at days 7,14, 28 and
42. Expression of these proteins nicely correlated with thickening
of the synovial lining layer comprising activated macrophages.
In contrast, in the mechanically induced DMM model, marginal
expression of both proteins was seen, only evident at day 7 af-
ter induction and consistent with limited synovial thickening. Of
interest, particularly the active form of S100A8 was expressed
in chondrocytes of cartilage areas in which lesions preferen-
tially developed at later time-points. When collagenase-induced-
osteoarthritis was elicited in S100A9-/- mice, signiﬁcantly lower
synovial activation was observed when compared to WT mice.
Synovial activation was 62% lower at day 42. In addition, cartilage
destruction was measured in various cartilage surfaces (medial
and lateral tibia and femur) of the knee joint. Cartilage destruction
was strongly and signiﬁcantly lower in all surfaces and ranged
from a 45% reduction in the lateral tibia to 73% reduction in the
medial femur. In line with this, MMP-mediated cartilage destruc-
tion (VDIPEN) was clearly present in cartilage of osteoarthritic
controls but markedly decreased in medial cartilage layers of day
42 osteoarthritic S100A9-/- mice, suggesting that S100A8/A9 are
involved in activating MMPs. We also showed that S100A8 stimu-
lates chondrocytes to upregulate and activate MMPs. In contrast,
in the DMM model, where S100A8 was hardly expressed in the
synovium, no differences in cartilage destruction were observed in
S100A9-/- and WT mice.
Conclusions: Alarmins S100A8/A9 play a crucial role in synovial
activation and cartilage destruction in an osteoarthritis model
that shows clear synovial involvement. S100A8/A9 expression in
the synovium causes pathology probably by stimulating MMP-
mediated damage in the cartilage matrix.
